Controls [n = 44] | MVP (all) [n = 80] | MVP (no significant MR) [n = 34] | “Borderline” MVP [n = 13] | |
---|---|---|---|---|
LVEDV (ml/m2) | 73 [67–90] | 98 [86–116]** | 90 [85–101]** | 83 [74–89] |
LVESV (ml/m2) | 30 [25–34] | 39 [31–445** | 37 [30–44]* | 35 [32–37] |
LVEF (%) | 61 [57–65] | 60 [57–66] | 60 [57–64] | 59 [56–62] |
LV mass (g/ m2) | 51 [42–59] | 54 [46–65] | 48 [43–59] | 47 [41–54] |
LV end-diastolic diameter (cm/ m2) | 2.6 [2.3–2.8] | 2.8 [2.5–3.2]** | 2.7 [2.5–3.2]* | 2.8 [2.5–2.9]* |
LV end-systolic diameter (cm/ m2) | 1.7 [1.5–2.0] | 1.9 [1.7–2.2]* | 1.9 [1.8–2.1]* | 1.9 [1.8–2.1] |
Basal inferolateral thickness in diastole (cm) | 0.7 [0.6–0.9] | 0.8 [0.7–1.0]* | 0.7 [0.6–0.9] | 0.7 [0.6–0.7] |
Basal inferolateral thickness in systole (cm) | 1.2 [1.1–1.4] | 1.5 [1.3–1.7]** | 1.5 [1.3–1.6]** | 1.3 [1.2–1.4] |
Mid inferolateral thickness in diastole (cm) | 0.6 [0.5–0.8] | 0.6 [0.5–0.7] | 0.6 [0.4–0.7]* | 0.4 [0.3–0.5]** |
Mid inferolateral thickness in systole (cm) | 1 [0.9–1.2] | 1 [0.8–1.2] | 1 [0.7–1.2] | 0.7 [0.6–0.8]** |
Basal-to-mid inferolateral end-diastolic thickness ratio | 1.1 [1–1.3] | 1.4 [1.1–1.7]** | 1.4 [1–1.6]* | 1.7 [1.3–1.7]** |
Basal-to-mid inferolateral end-systolic thickness ratio | 1.2 [1–1.4] | 1.5 [1.2–1.7]** | 1.6 [1.3–1.8]** | 1.9 [1.8–2.0]** |
RVEDV (ml/ m2) | 76 [69–86] | 85 [75–104]* | 85 [81–101]* | 74 [63–99] |
RVESV (ml/m2) | 33 [28–38] | 36 [28–47] | 37 [28–48] | 37 [27–42] |
RVEF (%) | 57 [55–62] | 59 [53–65] | 59 [53–63] | 56 [51–60] |
LA volume (ml/ m2) | 38 [30–43] | 50 [40–67]** | 41 [34–49] | 50 [36–59]* |
Mitral valve regurgitant fraction (%) | 4 [0–6] | 20 [11–32]* | 9 [1–13] | N/A |
LGE performed | 44 (100%) | 70 (85%) | 25 (74%) | 11 (85%) |
Myocardial LGE | 2 (5%) | 23 (33%)** | 8 (32%)* | 3 (27%) |
Intramyocardial pattern | 2 (5%) | 16 (23%)* | 4 (16%)* | 3 (27%) |
Inferolateral LGE | 0 (0%) | 22 (32%)* | 8 (33%)* | 2 (18%) |